How to determine the prognosis of renal function in CKD?
https://doi.org/10.36485/1561-6274-2022-26-3-102-109
Abstract
The presented material raises the most important question in practical nephrology – how to correctly assess kidney function to understand the prognosis and duration of the predialysis period in a particular patient with chronic kidney disease (CKD)? From the standpoint of onto- and phylogenesis, the hierarchy of kidney functions was assessed. It is noted that the existing approaches to such an assessment are convenient for practice, but do not sufficiently take into account individual characteristics and are devoid of a load component that can show kidney reserves. The authors focused on the functional renal reserve (FRR) and the possibility of its detection. The above technique with 0.45 % saline allows revealing the true functional capabilities of the kidneys and understanding the patient's capabilities in the pre-dialysis period. Conclusions are drawn about the convenient use of the KDIGO scale, a more individual approach when using the QxMD calculator, and the possibility of a personalized approach when assessing the FRR.
About the Authors
A. I. Gozhenko
Ministry of Health of Ukraine
Ukraine
Ukraine
Anatoly I. Gozhenko, Prof., MD, PhD, DMedSci, director
Ukrainian Research Institute of Transport Medicine
65039
Kanatnaya street, 92
Odessa
Phone: +380 048 728 14 52, +380 048 722 53 64
D. D. Ivanov
Shupyk National Healthcare University of Ukraine
Ukraine
Ukraine
Dmitry D. Ivanov, Prof., MD, PhD, DMedSci, Head of the Department
Department of Nephrology and Renal Replacement Therapy
01112
st. Dorogozhitskaya, 9
Kyiv
tel.: +38 (044) 2846897
References
1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter Suppl 2013; 3: 1–150
2. http://www.nice.org.uk/guidance/cg182/resources/guidance-chronic-kidney-disease-pdf
3. Ivanov D., Mintser O., Ivanova M. Adding elevated bp for CKD prognosis by GFR and albuminuria category NDT 2015 / 05 Vol. 30; Iss. suppl_3 doi 10.1093/ndt/gfv191.45
4. https://qxmd.com/calculate/calculator_347/chronic-kidney-disease-management-bc-guidelines
5. Гоженко А. И. Функциональный почечный резерв: физиология, патофизиология и диагностика. Применение в практике / А. И. Гоженко [и др.] – Киев: Издатель Заславский А. Ю., 2019. – 151 с
6. Кришталь М. В., Гоженко АІ, Сірман ВМ. Патофізіологія нирок / М. В. Кришталь, А. І. Гоженко, В. М. Сірманю. – Одеса: Фенікс, 2020. – 143 с
7. Lau Y. T., Cheng H. S., Hsieh C. C. Sodium transport in hypertension. Chin J Physiol 1992; 35 (3): 241–256. PMID: 1338308
8. Gagnon F., Hamet P., Orlov S. N. Na+,K+ pump and Na+-coupled ion carriers in isolated mammalian kidney epithelial cells: regulation by protein kinase C. Can J Physiol Pharmacol 1999 May; 77 (5): 305–319. PMID: 10535680
9. Riese K., Beyer A. T., Lui G. M., Crook R. B. Dopamine D1 stimulation of Na+,K+,Cl- cotransport in human NPE cells: effects of multiple hormones. Invest Ophthalmol Vis Sci. 1998 Jul; 39 (8): 1444–1452. PMID: 9660493
10. Cherney D. Z. I., Ferrannini E., Umpierrez G. E. et al. Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment. Diabetes Obes Metab 2021 Aug 2. doi: 10.1111/dom.14513. (Original study)
11. Gagnon F., Hamet P., Orlov S. N. Na+, K+ pump and Na+-coupled ion carriers in isolated mammalian kidney epithelial cells: regulation by protein kinase C. Can J Physiol Pharmacol 1999 May; 77 (5): 305–319. PMID: 10535680
12. Orlov S. N., Hamet P. Intracellular monovalent ions as second messengers. J Membr Biol. 2006 Apr; 210 (3): 161–172. doi: 10.1007/s00232-006-0857-9. Epub 2006 Aug 14. PMID: 16909338
13. Urazaev A. Kh. Natriĭ-kaliĭ-khlornyĭ kotransport kletochnoĭ membrany [The sodium-potassium-chloride cotransport of the cell membrane]. Usp Fiziol Nauk 1998 Apr-Jun; 29 (2): 12–38. Russian. PMID: 9659682
14. Gallaher J., Bier M., Siegenbeek van Heukelom J. The role of chloride transport in the control of the membrane potential in skeletal muscle – theory and experiment. Biophys Chem 2009 Jul; 143 (1-2): 18–25. doi: 10.1016/j.bpc.2009.03.008. Epub 2009 Mar 25. PMID: 19361905
15. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Deepak L. Bhatt, MD, MPH, Michael Szarek, PhD, Bertram Pitt, MD, Christopher P. Cannon, MD, Lawrence A. Leiter, MD, Darren K. McGuire, MD, MHSc, Julia B. Lewis, MD, Matthew C. Riddle, MD, Silvio E. Inzucchi, MD, Mikhail N. Kosiborod, MD, David Z. I. Cherney, MD, PhD, Jamie P. Dwyer, MD et al, for the SCORED Investigators*N Engl J Med 2021; 384: 129–139
16. Иванов Д. Д. Влияние COVID-19 на функцию почек у пациентов с артериальной гипертензией 1–2 степени и хронической болезнью почек / Д. Д. Иванов [и др.] // Нефрология. – 2022. – 26 (1): 34–43. doi: 10.36485/1561-6274-2022-26-1-34-43 / Ivanov D. D., Gozhenko A. I., Ivanova M. D., Zavalnaya I. N. Effect of COVID-19 on kidney function in patients with arterial hypertension grade 1–2 and CKD. Nephrology (Saint-Petersburg). 2022; 26 (1): 34–43. (In Russ.). https://doi.org/10.36485/1561-6274-2022-26-1-34-43
17. Aronson J. K., Ferner R. E. Drugs and the renin-angiotensin system in covid-19. BMJ 2020 Apr 2; 369: m1313. doi: 10.1136/bmj.m1313
18. Aroca-Martínez G., Musso C. G., Avendaño-Echavez L., Vélez-Verbel M., Chartouni-Narvaez S., Hernandez S., Hinojosa-Vidal M. A., Espitaleta Z., Cadena-Bonfanti A. Differences between COVID-19-induced acute kidney injury and chronic kidney disease patients. J Bras Nefrol 2022 Feb 28: S0101-28002022005018401. English, Portuguese. doi: 10.1590/2175-8239-JBN-2021-0161
19. Иванов Д. Д. Технология сохранения функции почек у людей с ХБП и гиперурикемией // Сборник тезисов III Международной научно-практической конференции «Здоровые почки – здоровая жизнь», посвященной Всемирному дню почки – 2022, 25 марта 2022 года. – 81–85 / Ivanov D. D., Kushnirenko S. V., Melnik I. I. et al. Technology of renal function preservation in people with CKD and hyperuricemia. III International Scientific and Practical Conference "Healthy kidney – healthy life", dedicated to World Kidney Day – 2022, March 25, 2022, 81–85
20. Ivanov D. D., Ivanova M. D. Febuxostat improves GFR and BP in non-diabetic adults with CKD 2-3: 4 years follow-up – NDT, 2015, SP 326
21. Иванов Д. Д. Индивидуализация ренопротекции в зависимости от расчетной скорости клубочной фильтрации и функционального резерва почек / Д. Д. Иванов, А. И. Гоженко, Л. М. Савицкая // Нефрология. – 2019. – 23 (1): 9–14. URL: https://journal.nephrolog.ru/jour/article/view/1659 / Ivanov D. D., Gozhenko A. I., Savytska L. M. Individualization of renoprotection in dependence from estimated glomerular filtration rate and renal functional reserve. Nephrology (Saint-Petersburg) 2019; 23 (1): 9–14 (In Russ.). URL: https://journal.nephrolog.ru/jour/article/view/1659
22. Ivanov D., Savytska L , Kulachek V. The association of kidney stress test with water salt loading with estimated glomerular filtration rate decline in patients with chronic kidney disease stage 1-3. Archives of the Balkan Medical Union Balkan Medical Union Sept 2019; 54 (3): 11–17
23. Иванов Д. Гидратация: обзор 3 исследований / Д. Иванов, М. Иванова // Почки. – 2020. – 9 (1)
24. Ivanova M. D., Gozhenko A. I., Crestanello T., Ivanov D. D. Early Coaching to Increase Water Intake in CKD. Ann Nutr Metab Received: January 29, 2020 Accepted: February 5, 2021 Published online. doi: 10.1159/000515276
25. Ivanov D. D., Ivanova M. D. Hydration: the review of 3 trials Počki. 2020; 9 (1): 10–13. doi: 10.22141/2307-1257.9.1.2020.196911
Review
For citations:
Gozhenko A.I., Ivanov D.D. How to determine the prognosis of renal function in CKD? Nephrology (Saint-Petersburg). 2022;26(3):102-109. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-3-102-109
Views:
533
Email this article 